TROP2 expression a promising predictor of clinical outcomes in patients with advanced or metastatic NSCLC
New data presented today demonstrate that TROP2 expression as measured by quantitative continuous scoring (QCS), a computational pathology approach, is a promising predictor of clinical outcomes in patients with advanced ...
Sep 8, 2024
0
0